Drug trial shows rectal cancer in remission in all patients.
An experimental drug appeared to rid people of rectal cancer in an unprecedented study, according to The New York Times. A group comprising 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of… Continue Reading